April 2, 2012
BioScale, Inc. a life science company that develops ultrasensitive protein analysis technology, presented findings of recently completed research studies on phospho-protein analysis of the activation state of the MAP kinase pathway at the 103rd Annual Meeting of the American Association for Cancer Research (AACR), held at McCormick Place in Chicago, Illinois, March 31 - April [...]
Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012
April 1, 2012
CARLSBAD, Calif.,-- Life Technologies Corporation (NASDAQ: LIFE) will exhibit products across the spectrum of basic, translational and clinical cancer research during the American Association of Cancer Research (AACR) Annual Meeting 2012, taking place March 31 – April 4, in Chicago, Illinois. In addition, several of Life's customers and collaborators will present research findings. "From basic [...]
April 1, 2012
NEW YORK, NY,– Enzo Biochem Inc.announced that the Company yesterday made its first peer-reviewed presentation of its novel AmpiProbe™ platform, encompassing low cost, and high sensitivity, real time nucleic acid amplification and detection assays, at the annual meeting in London of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). The Company’s presentation, titled [...]
March 31, 2012
LONDON -- At the 22nd ECCMID (European Congress of Clinical Microbiology and Infectious Diseases) in London, Bruker announces a collaboration with UMCG within the new European Network for the Rapid Identification of Anaerobes (ENRIA), based on Bruker´s MALDI Biotyper system for MALDI-TOF mass spectrometry-based microbial identification. Anaerobic infections belong to the neglected infectious diseases and [...]
March 30, 2012
MILFORD, Mass.,-- The Waters Corporation today announced VICAM®, a Waters® Business, introduced the Fumo-V™ strip test, the newest member of its quantitative strip test family. Designed to work with the portable Vertu™ Lateral Flow Reader, Fumo-V uses the proven sensitivity and selectivity of VICAM's monoclonal antibodies to accurately detect and measure fumonisin B1, B2, and [...]
March 30, 2012
Austin, Texas – Asuragen, Inc. announced today that the Company received notice of a $6.8 million commercialization award to pursue Next Generation Sequencing (NGS) applications from the State of Texas through the Cancer Prevention and Research Institute of Texas (“CPRIT”). CPRIT was established to expedite innovation and commercialization in the area of cancer research and [...]
March 30, 2012
The partnership enables CAMO Software’s Unscrambler® X multivariate analytical engines to be offered together with Optimal’s synTQ® Lite software, designed for PAT (Process Analytical Technology) environments in the life sciences industry. CAMO Software CEO, Paal Braathen, says, ”We are very pleased to be working more closely with Optimal, an established leader in process automation. Our [...]
NanoString Introduces Three New Products at AACR Annual Meeting
March 30, 2012
SEATTLE, Wash. – NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced that it will launch three new products for the nCounter® Analysis System at the American Association of Cancer Research (AACR) Annual Meeting 2012, March 31-April 4, in Chicago, Ill. NanoString’s suite [...]
March 30, 2012
DALLAS-- Food safety testing is now on wheels, and it’s coming to Dallas as part of a progressive North American tour to raise awareness about improving food safety. A state-of-the-art mobile laboratory that is run by AB SCIEX and Phenomenex, two scientific technology leaders, will be open for visitors at the Frito-Lay North America site [...]
Block MEMS Wins Contract to Participate in the Multi-Mission Multi-Threat Detection (M3TD) Program
March 30, 2012
Block MEMS has been awarded a contract by the Department of Defense's Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) to provide its LaserScan™ Analyzer for evaluation in the Multi-Mission Multi-Threat Detection (M3TD) Technology Evaluation program. The goal of the M3TD program is to evaluate currently available technology for chemical detection and the [...]
